PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1324889
PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1324889
Loratadine syrup is a medication used to provide relief from allergy symptoms. This is known for its non-drowsy formula, making it suitable for daytime use without causing significant sedation. It effectively alleviates symptoms like sneezing, runny nose, itching, and watery eyes associated with allergies, providing long-lasting relief. The syrup formulation offers convenience, particularly for pediatric populations or individuals who have difficulty swallowing pills, as it allows for easy administration and accurate dosing. The loratadine syrup market is experiencing steady growth and is driven by several key factors such as the increasing prevalence of allergies, such as seasonal allergies, hay fever, and allergic rhinitis, which has fueled the demand for loratadine syrup. For instance, according to an article published by a U.S. organization, 339 million are suffering from asthma, 200 to 250 million have a food allergy and 400 million have rhinitis globally.
The loratadine syrup market is expected to grow at a steady rate of around 2% owing to Its over-the-counter availability, favorable safety profile, and non-drowsy formula making it a preferred choice for consumers across different age groups. Moreover, the growing awareness about allergies and their impact on health, coupled with the urbanization and environmental factors contributing to allergen exposure, has bolstered the market demand for loratadine syrup.
Based on age, the market is segmented into adult and pediatric. The pediatric category is to witness a higher CAGR during the forecast period. This is mainly due to the high prevalence of allergies and hay fever in children, consider a safe medication for children and long-acting formulations. For instance, in 2021, around 81 million people in the U.S. were diagnosed with seasonal allergic rhinitis (hay fever). This equals around 26% (67 million) of adults and 19% (14 million) of children.
On the basis of indication, the market is categorized into allergic rhinitis and urticaria. Among these, allergic rhinitis held a significant share of the market in 2021. This is mainly due to the growing investment & funding activities by government bodies and the rising prevalence of allergic rhinitis all over the world. For instance, as per the National Institutes of Health (NIH), around 339 million are suffering from asthma, 200 to 250 million have a food allergy and 400 million have rhinitis globally.
Based on drug type, the loratadine syrup market has been classified into branded and generic. The branded category is to witness higher adoption of loratadine syrup during the forecast period. This is mainly due to the pharmaceutical companies spending on marketing & branding and their loyalty being higher. Also, brand-name pills are usually the first version of the drug on the market, and this specific version has undergone careful testing to ensure efficacy to consumers.
For a better understanding of the market adoption of the loratadine syrup industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. the large population, coupled with increasing urbanization and industrialization, has led to a rise in allergy cases in the region. APAC also experiences a higher prevalence of allergic rhinitis due to environmental factors. For instance, as per an article published by the National Library of Medicine (NLM), with more than 1.35 billion people, India is home to nearly 20% of the global population. Of all chronic diseases, allergic diseases such as allergic rhinitis (AR) and asthma seem to increase in India over the past few years. Approximately, 22% of adults at present experience allergic rhinitis (AR) in the region. As a result, there is an increasing demand for effective allergy relief medications like loratadine syrup. The growing middle class, rising healthcare expenditure, and improving healthcare infrastructure in countries like China, India, and Japan contribute to the market growth. Additionally, the availability of loratadine syrup as an OTC medication in several countries within the APAC region makes it easily accessible to consumers.
Some of the major players operating in the market include: Merck KGaA; Cadila Pharmaceuticals; Medico Remedies Limited; Sun Pharmaceutical Industries Ltd.; GSK plc.; Perrigo Company plc; Novartis AG; Taro Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; and Bayer Inc.